Qure advances its pathology-shifting AMT-130 therapy for Huntington's disease; pivotal data and commercial launch prep target 2025 milestones.

Q2 2025 Earnings Call Transcript August 1, 2025 Enbridge Inc. beats earnings expectations. Reported EPS is $0.47, ...

The head of Enbridge Inc. says he's encouraged by conversations in both Canada and the U.S. on building more energy ...

Revenue (GAAP) rose 20.4% year over year to $1.373 million, beating analyst estimates by nearly three-fold (GAAP revenue was $1.373 million vs. analyst estimate of $0.47 million, a 194.2% beat). Net ...

Canada needs more options to get its energy to new markets. This TSX dividend stock is in a prime position to prosper in the coming years.

TC Energy has announced plans to construct the Leming Lake Lateral Loop, a 17-km pipeline, in Lac La Biche County.

South West-based student accommodation group Unite achieved 15% growth in earnings during the first half of this year as high ...

Q2 2025 Earnings Call Transcript August 1, 2025 Operator: Good day, ladies and gentlemen. Thank you for joining us on ...

July 31, 2025) - Above Food Ingredients Inc. (NASDAQ: ABVE) ("Above Food" or the "Company") today issued an update regarding its proposed merger with Palm Global Technologies Limited ("Palm Global"), ...

Operator: Welcome to the Radware conference discussing Second Quarter 2025 results, and thank you all for holding.

Agios Pharmaceuticals gears up for a pivotal 2025 with key PYRUKYND milestones, including FDA decisions for thalassemia.

GEO-MVA received favorable European regulatory guidance supporting streamlined development pathway GEO-CM04S1 demonstrates ...